tiprankstipranks
Advertisement
Advertisement

GDTC Stock Latest News

CytoMed Chairman Boosts Personal Stake and Funds R&D Expansion at LongevityBank
Company AnnouncementsCytoMed Chairman Boosts Personal Stake and Funds R&D Expansion at LongevityBank
18d ago
6K
GDTC
CytoMed Therapeutics Shareholders Approve All Resolutions at May 22 AGM
PremiumCompany Announcements
CytoMed Therapeutics Shareholders Approve All Resolutions at May 22 AGM
1M ago
6K
GDTC
CytoMed Chairman Moves to Boost Personal Stake Through Private Share Purchases
PremiumCompany Announcements
CytoMed Chairman Moves to Boost Personal Stake Through Private Share Purchases
2M ago
6K
GDTC
CytoMed Renames Subsidiary to Drive Asian and International Expansion
PremiumCompany Announcements
CytoMed Renames Subsidiary to Drive Asian and International Expansion
2M ago
6K
GDTC
CytoMed Therapeutics Sets May 22, 2026 AGM With Expanded Share-Issuance Mandate on the Table
PremiumCompany Announcements
CytoMed Therapeutics Sets May 22, 2026 AGM With Expanded Share-Issuance Mandate on the Table
3M ago
6K
GDTC
CytoMed Therapeutics Widens 2025 Loss as It Accelerates Cell Therapy Trials and Southeast Asia Expansion
PremiumCompany AnnouncementsCytoMed Therapeutics Widens 2025 Loss as It Accelerates Cell Therapy Trials and Southeast Asia Expansion
3M ago
6K
GDTC
CytoMed Therapeutics Refutes Misleading Claims, Confirms Ongoing First-in-Human Trial
Premium
Company Announcements
CytoMed Therapeutics Refutes Misleading Claims, Confirms Ongoing First-in-Human Trial
5M ago
6K
GDTC
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress
Premium
The Fly
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress
5M ago
GDTC
CytoMed Therapeutics Outlines 2026 Clinical Plans and Seeks Shareholder Input on Patient-Access Scheme
PremiumCompany Announcements
CytoMed Therapeutics Outlines 2026 Clinical Plans and Seeks Shareholder Input on Patient-Access Scheme
6M ago
6K
GDTC
Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’
PremiumThe Fly
Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’
6M ago
GDTC
CytoMed Therapeutics Partners with Malaysian Hospital for Groundbreaking Cancer Trial
PremiumCompany Announcements
CytoMed Therapeutics Partners with Malaysian Hospital for Groundbreaking Cancer Trial
7M ago
6K
GDTC
Cytomed Therapeutics enters into MoU with UMMC
PremiumThe Fly
Cytomed Therapeutics enters into MoU with UMMC
7M ago
GDTC
CytoMed completes acquisition of T cell technology of TC BioPharm
PremiumThe FlyCytoMed completes acquisition of T cell technology of TC BioPharm
8M ago
GDTC
CytoMed Therapeutics Finalizes Acquisition of T Cell Technology for Cancer Treatment in China and India
Premium
Company Announcements
CytoMed Therapeutics Finalizes Acquisition of T Cell Technology for Cancer Treatment in China and India
8M ago
6K
GDTC
Cytomed Therapeutics secures investment for subsidiary LongevityBank
Premium
The Fly
Cytomed Therapeutics secures investment for subsidiary LongevityBank
8M ago
GDTC
CytoMed Therapeutics Secures Investment and Advances China Strategy
PremiumCompany Announcements
CytoMed Therapeutics Secures Investment and Advances China Strategy
8M ago
6K
GDTC
CytoMed Therapeutics’ ANGELICA Trial: A New Frontier in Cancer Treatment
PremiumCompany Announcements
CytoMed Therapeutics’ ANGELICA Trial: A New Frontier in Cancer Treatment
9M ago
GDTC
CytoMed Therapeutics’ Chairman Boosts Stake Amid Biotherapeutics Growth
PremiumCompany Announcements
CytoMed Therapeutics’ Chairman Boosts Stake Amid Biotherapeutics Growth
9M ago
6K
GDTC
Cytomed Therapeutics chairman Peter Choo increases holdings to 21.95%
PremiumThe Fly
Cytomed Therapeutics chairman Peter Choo increases holdings to 21.95%
9M ago
GDTC
CytoMed Therapeutics Bids for TC BioPharm’s Assets Amid Strategic Expansion
PremiumCompany AnnouncementsCytoMed Therapeutics Bids for TC BioPharm’s Assets Amid Strategic Expansion
9M ago
6K
GDTC
Cytomed announces cash bid for potential acquisition of TC BioPharm
Premium
The Fly
Cytomed announces cash bid for potential acquisition of TC BioPharm
9M ago
GDTC
CytoMed Therapeutics Unveils Promising AML Therapy Research
Premium
Company Announcements
CytoMed Therapeutics Unveils Promising AML Therapy Research
9M ago
6K
GDTC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >